Status:
UNKNOWN
Experience Sampling Method in OAB Patients
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
Zuyderland Hospital
University Hospital, Antwerp
Conditions:
Overactive Bladder
Overactive Bladder Syndrome
Eligibility:
All Genders
18-70 years
Brief Summary
Rationale: The overactive bladder syndrome is diagnosed clinically by using the ICS criteria of ≥8 micturitions and at least 1 urgency episode per 24 hours. To determine whether patients fit the crite...
Detailed Description
The overactive bladder syndrome (OAB) is defined by the International Continence Society (ICS) as a symptom complex of urgency, usually with frequency and nocturia (awakening at night to void), with (...
Eligibility Criteria
Inclusion
- Inclusion criteria OAB patients Patients between 18-70 years with either subjectively experienced OAB for which they have sought medical help or have been diagnosed with OAB by a medical physician. Participants need to be able to understand written Dutch and speak the Dutch language, since the ESM app will be conducted in Dutch. They also have to understand how to practice the ESM tool.
- Inclusion criteria healthy volunteers
- Age between 18 and 70 years;
- Male and female
- Ability to understand and speak Dutch;
- Ability to understand how to utilize the ESM tool.
- Exclusion criteria OAB patients
- A potential subject who meets any of the following criteria will be excluded from participation in this study:
- Patients with a clear anatomical or other urological cause for OAB (e.g. bladder cancer, benign prostate hyperplasia (BPH), prostate cancer, urolithiasis, chronic or acute urinary tract infections (UTI), neurological disease).
- Patient with severe stress incontinence
- Pregnancy
- Exclusion criteria healthy volunteers
- Current or past diagnosis of lower urinary tract symptoms;
- No more than one urinary tract infection in half a year.
- Start-up of regularly used medication from one month before inclusion until the end of study participation.
- Pregnancy
Exclusion
Key Trial Info
Start Date :
August 6 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 5 2021
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT03435991
Start Date
August 6 2018
End Date
January 5 2021
Last Update
February 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht Univeristy Medical Center+
Maastricht, Netherlands